1436872-33-1

Basic information

• Product Name: (E)-3-(3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)-1-(p-tolyl)prop-2-en-1-one
• Synonyms: (E)-3-(3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)-1-(p-tolyl)prop-2-en-1-one
• CAS NO: 1436872-33-1
• Molecular Weight: 294.35
• Mol File: 1436872-33-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (E)-3-(3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)-1-(p-tolyl)prop-2-en-1-one(CAS DataBase Reference)
• NIST Chemistry Reference: (E)-3-(3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)-1-(p-tolyl)prop-2-en-1-one(1436872-33-1)
• EPA Substance Registry System: (E)-3-(3,4-dihydro-2H-benzo[b][1,4]dioxepin-7-yl)-1-(p-tolyl)prop-2-en-1-one(1436872-33-1)

Safety Data

• Hazardous Substances Data: 1436872-33-1(Hazardous Substances Data)

Upstream product

• 67869-90-3 3,4-dihydro-2H-benzo[b][1,4]dioxepine-7-carbaldehyde 
• 122-00-9 para-methylacetophenone 
• 139-85-5 3,4-dihydroxybenzaldehyde 

Relevant articles and documents

4,5-Dihydropyrazole derivatives containing oxygen-bearing heterocycles as potential telomerase inhibitors with anticancer activity

Telomere and telomerase were closely related to the occurrence and development of some cancers. After the key active site of telomerase was identified, to enhance the ability of dihydropyrazole derivatives to inhibit telomerase, we designed a series of novel 4,5-dihydropyrazole derivatives containing heterocyclic oxygen moiety based on previous studies. The telomerase inhibition assay showed that compound 10a displayed the most potent inhibitory activity with an IC50 value of 0.6 μM for telomerase. The antiproliferative assay showed that 10a exhibited high activity against human gastric cancer cell SGC-7901 with an IC50 value of 10.95 ± 0.60 μM. Flow cytometric analysis and western blot results showed that 10a induced both apoptosis and autophagy. A docking simulation showed that 10a could bind well to the active site of telomerase and act as a telomerase inhibitor. The 3D-QSAR model was also built to provide a more pharmacological understanding that could be used to design new agents with more potent telomerase inhibitory activity.